Follow RSS for latest reports on this topicNexium - Market Research and Reports

Nexium is the 2nd most profitable drug in 2009, according to 2009 annual sales figures, where it generated just over $5m in sales for its company, AstraZeneca Pharmaceuticals. 

Nexium is a proton pump inhibitor, acting to reduce the amount of acid produced by the stomach. Reducing the acid production reduces the symptoms and the risks of some diseases including gastric ulcers, GERD and Zollinger-Ellison syndrome.

Source; BioPortfolio and

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found 4 reports that matched your search.

Refine your search, and find more matches, using the form above.

We Stock...